Previous 10 | Next 10 |
2023-10-15 17:00:00 ET Summary There are several clear reasons to consider Progyny stock. The company's worth is overlooked, making it a sneaky value play for investors. Here's how Progyny's unique position in the industry and financial health make it an attractive acquisition...
2023-09-27 10:16:00 ET A lot is going on in the world of growth stocks outside of the artificial intelligence (AI) names that investors are excited about. Investors can find stocks worth a look in digital advertising, robotic-assisted surgery, and even fertility care. Recent pullbacks m...
NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Progyny , Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced their nearly five-year partnership with Amazon has reached a milestone number of more than 30,000 ...
2023-08-21 12:38:02 ET Summary Progyny's 2Q23 results demonstrate strong performance and resilience, with revenues increasing by 43%. The company is benefiting from a strong secular tailwind in the fertility benefits market and has a promising pipeline of new clients. Progyny'...
NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the strategic expansion of its extensive managed reproductive health network to include specialize...
2023-08-03 22:29:11 ET Progyny, Inc. (PGNY) Q2 2023 Earnings Conference Call August 3, 2023, 04:45 PM ET Company Participants James Hart - IR Pete Anevski - CEO Michael Sturmer - President Mark Livingston - CFO Conference Call Participants Michael...
2023-08-03 16:04:20 ET Progyny press release ( NASDAQ: PGNY ): Q2 GAAP EPS of $0.15 beats by $0.05 . Revenue of $279.4M (+43.3% Y/Y) beats by $17.23M . Adjusted EBITDA was $47.5 million, an increase of 44% as compared to the $32.9 million reported in the seco...
Reports Record Quarterly Revenue of $279.4 Million, Reflecting 43% Growth Over the Prior Year Period Achieves Record Quarterly Operating Cash Flow of $76.0 Million Raises Full Year Revenue and Earnings Guidance Continuing to See Strong Employer Demand for Fertility and Family Building Solut...
2023-08-03 08:55:11 ET Summary Humana's shares spiked after exceeding analysts' expectations for Q2 revenue and adjusted earnings per share. The company's Insurance segment performed particularly well, and this trend looks set to continue. While there was a downward revision f...
2023-07-28 02:55:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. During the second quarter, the U.S. Small Company Growth Composite Portfolio returned 4.10% gross a...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building survey. The report, which surveyed over 1,100 LGBTQ+ individuals in the ...